AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Continuous vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids In Distress)

RecruitingNAAges 1 Year - 11 YearsAllUniversity of British Columbia
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this intervention study is to evaluate the difference in nutrition status markers (weight and muscle mass) when giving dietary protein by continuous or bolus delivery in critically ill children ages 1-11y. The main questions it aims to answer are: Primary: Bolus protein delivery will lessen the decline in mid-upper arm circumference (MUAC) z-score by 0.5 standard deviation in critically ill children aged 1-11y after 1wk. Ultrasound will correlate to MUAC. Secondary: Bolus protein delivery will provide more (grams per day) than when provided continuously, therefore it is more likely to meet the minimum estimated needs. Participants will have daily nutrition intake data collected, and undergo body composition measures (weight, MUAC and ultrasound of the upper thigh muscle) at day of enrollment, and MUAC/Ultrasound on follow up days 3, 5, 7 and 14 after the intervention star

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Children admitted to PICU over 1 year of age and younger than 11 years of life * Expected to remain in the pediatric intensive care unit for longer than 72 hours * Receiving standard pediatric formula via NGT/OGT/GT Exclusion Criteria: * Neuromuscular condition such as muscular dystrophy * Admitted with home prescription for high dose steroids, receives growth hormone or insulin * Enteral nutrition is contraindicated or if nutrition requirements are partially/fully met by parenteral nutrition * Formula delivered into the small bowel (duodenum/jejunum, NJT/GJ) * Those who require a highly specialized diet (E.g., large burns or metabolic diseases) * Patients with a cow's milk protein allergy cannot safely receive a whey-based protein supplement
๐Ÿ’Š

What it tests

  • Dietary protein
๐Ÿ“

Where

1 site
BC Childrens Hospital
Vancouver, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy